California, Massachusetts Join Washington State In Stockpiling Abortion Pills | Wayne Dupree

After a judge in a Texas federal court issued a ruling this week that might ban the nationwide use of abortion pills, two Democratic-led states began stockpiling the medication. While the Biden administration appeals U.S. District Judge Matthew Kacsmaryk’s ruling on Friday that the FDA’s approval of mifepristone 23 years ago was unlawful, California Governor Gavin Newsom said on Monday that his state had secured about 2 million pills of misoprostol and Massachusetts had stockpiled 15,000 doses of mifepristone.

California Governor Gavin Newsom claimed in a press statement that the state had procured a stockpile of an alternate medication abortion pill in response to a “extremist ban” on a medication abortion drug. No matter how much fanatics try to ban abortion services, we will not back down. Abortion using medication is still permitted in the Golden State.

According to the announcement, California bought the supply of misoprostol in preparation for Kacsmaryk’s verdict.


On Monday, Governor Maura Healy told reporters that “abortion will remain safe, legal, and accessible here in Massachusetts,” and that the state’s stockpile of 15,000 pills would be enough to last for nearly a year.

Healy was joined by Senator Elizabeth Warren, Representative Ayanna Presley, and Attorney General Andrea Campbell of Massachusetts. They assured the public that the Biden administration would take measures to safeguard women’s access to abortion.

They can take many different actions,” Warren added. And right off the bat, they started filing an appeal of the verdict in court. This radical judge from Texas reminds us that Roe v. Wade will be on the ballot in four years.

The Biden administration argued Monday that the lawsuit challenging the FDA’s 2000 approval of mifepristone is “manifestly untimely” and that the group of anti-abortion rights physicians and medical associations that targeted access to the drug lack the legal standing to challenge the FDA’s approval of mifepristone, which they neither take nor prescribe.

On the same day, however, a federal district judge in Washington issued a separate order that prevents the FDA from changing the status quo with regards to mifepristone’s availability in 16 states and the District of Columbia, further complicating the legal situation. These states and the District of Columbia filed a lawsuit against the Biden administration in February to prevent the drug’s availability from being severely curtailed.

In order to better understand its responsibilities under the order, the Justice Department has contacted the relevant court for clarification.

Leave a Comment